Pairwise Affinity is a technology company with expertise in visual neuroscience and scientific computing.
We are currently developing innovative vision-testing systems for research and clinical applications.
Today, clinical vision trials still rely on letter charts to characterize how well people see.
Our next generation vision-testing technology provides greater sensitivity to measure and track changes in visual function that occur with various retinal diseases.
This greater sensitivity will enable pharmaceutical companies to accelerate the development of effective therapies and bring new sight-saving drugs to patients sooner.
We will have more exciting announcements to share with you soon.